J&J: Austria as Key Research Hub – Benefits for People & Economy

Despite a challenging global economic climate, Johnson & Johnson’s pharmaceutical division, J&J Innovative Medicine, is demonstrating a strong commitment to research and growth in Austria. The company completed 37 clinical studies within the country in 2024, reaffirming Austria’s key role in J&J’s global research network and highlighting the ongoing investment in innovative healthcare solutions. This continued focus underscores the importance of international collaboration in advancing medical breakthroughs.
Standort Österreich. Forschung zahlt sich dreifach aus: für Menschen, Gesellschaft und Wirtschaft
        </aside>
        <p>Johnson &amp; Johnson’s pharmaceutical arm, J&amp;J Innovative Medicine, is continuing to invest heavily in clinical research, particularly in Austria, even as many companies scale back their research and development budgets. The company completed 37 studies in Austria alone during 2024, underscoring the country’s importance as a key research hub within the global organization.</p><figure class="fm-inlinepicture fm-inlinepicture--standard figure flexmodule vued">     <picture class="figure__picture">                         <source media="(-webkit-min-device-pixel-ratio: 1.5)" srcset="     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_600/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 560w,     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 746w,     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 876w,     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 1022w,     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 1308w,     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 1508w,     https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg 1802w " sizes="     (max-width: 759px) calc(100vw - 40px),     (min-width: 760px) and (max-width: 1023px) calc(100vw - 80px),     (min-width: 1024px) and (max-width: 1279px) calc((100vw - 580px) / 12 * 8 + 140px),     (min-width: 1280px) and (max-width: 1424px) calc(100vw - 720px),     (min-width: 1425px) and (max-width: 1579px) calc((100vw - 900px) / 12 * 8 + 140px),     (min-width: 1580px) 607px, 607px "/> <img class="figure__image" src="https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg" alt="Sara Leitao, Managing Director von J&amp;J Innovative Medicine in Österreich." width="1000" height="600" loading="lazy" fetchpriority="low"/>                  <photo-lightbox src="https://img.diepresse.com/public/incoming/n4xmes-JJ_Foto_Sara-Leitao_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Sara%20Leitao_C%20Thomsen-Photography.jpg" caption="&lt;div&gt;&lt;span&gt;Sara Leitao, Managing Director von J&amp;J Innovative Medicine in Österreich.&lt;/span&gt; &lt;span class=&quot;figure__credits&quot;&gt;C Thomsen Photography&lt;/span&gt;&lt;/div&gt;"/>     </picture>     <figcaption class="figure__caption">         <p><span>Sara Leitao, Managing Director von J&amp;J Innovative Medicine in Österreich.</span> <span class="figure__credits">C Thomsen Photography</span></p>     </figcaption> </figure>  <p>“Our country has become established as a core location for clinical research within the company,” said Sara Leitao, Managing Director of J&amp;J Innovative Medicine in Austria.  The continued investment reflects J&amp;J’s commitment to developing new therapies and addressing unmet medical needs, a strategy that is particularly important in a challenging global healthcare landscape.</p>
        <p>J&amp;J Innovative Medicine’s overarching goal is to improve the quality of life for patients. “We consistently invest in research and development to create new treatment options – with the hope of one day being able to cure diseases that are currently incurable,” Leitao stated.</p>
        <p>Globally, Johnson &amp; Johnson invests approximately $13 billion USD annually in research and development, representing around 23% of its total revenue. A significant focus is placed on precision medicine, with the company aiming to provide each patient with the most effective, individualized therapy possible, according to Birgit Ploier-Brandauer, Medical Affairs Director at J&amp;J in Austria.</p>
        <figure class="fm-inlinepicture fm-inlinepicture--standard figure flexmodule vued">     <picture class="figure__picture">                         <source media="(-webkit-min-device-pixel-ratio: 1.5)" srcset="     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_600/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 560w,     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 746w,     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 876w,     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 1022w,     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 1308w,     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 1508w,     https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg 1802w " sizes="     (max-width: 759px) calc(100vw - 40px),     (min-width: 760px) and (max-width: 1023px) calc(100vw - 80px),     (min-width: 1024px) and (max-width: 1279px) calc((100vw - 580px) / 12 * 8 + 140px),     (min-width: 1280px) and (max-width: 1424px) calc(100vw - 720px),     (min-width: 1425px) and (max-width: 1579px) calc((100vw - 900px) / 12 * 8 + 140px),     (min-width: 1580px) 607px, 607px "/> <img class="figure__image" src="https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1200/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg" alt="Birgit Ploier-Brandauer, Medical Affairs Director bei J&amp;J in Österreich." width="1000" height="600" loading="lazy" fetchpriority="low"/>                  <photo-lightbox src="https://img.diepresse.com/public/incoming/nw3996-JJ_Foto_Birgit-Ploier_C-Thomsen-Photography.jpg/alternates/WEBP_FREE_1800/JJ_Foto_Birgit%20Ploier_C%20Thomsen%20Photography.jpg" caption="&lt;div&gt;&lt;span&gt;Birgit Ploier-Brandauer, Medical Affairs Director bei J&amp;J in Österreich.&lt;/span&gt; &lt;span class=&quot;figure__credits&quot;&gt;C Thomsen Photography&lt;/span&gt;&lt;/div&gt;"/>     </picture>     <figcaption class="figure__caption">         <p><span>Birgit Ploier-Brandauer, Medical Affairs Director bei J&amp;J in Österreich.</span> <span class="figure__credits">C Thomsen Photography</span></p>     </figcaption> </figure>  <p>As an example, J&amp;J has developed different treatment options for multiple myeloma, a complex blood cancer, based on varying stages and forms of the disease. “Patients in Austria often have early access to our new therapies worldwide,” Ploier-Brandauer added. Significant progress is also being made in lung cancer treatment, with extended survival rates observed in certain carcinomas.  Another key research area focuses on innovative therapies for bladder, or urothelial, cancer.</p>
        <p>“Our research puts patients at the center – but it also has positive effects on society,” Ploier-Brandauer explained. “Innovative therapies help to relieve the burden on the healthcare system, reduce costs, and keep people in the workforce longer.”  The company’s approach recognizes that health is fundamental to individual opportunity, societal progress, and economic prosperity.</p>
        <p>Currently, approximately 40 innovative therapy options from J&amp;J Innovative Medicine are approved for use in Austria in various combinations.  Beyond medication, the company is focused on patient support. “We don’t just want to provide modern medicines, but also help with orientation in the new life situation,” Ploier-Brandauer said.  J&amp;J supports patients with comprehensive informational materials, including brochures and a digital cancer guide.</p>
        <p>CP-551225, Janssen-Cilag Pharma GmbH</p>
        <figure class="fm-inlinepicture fm-inlinepicture--standard figure flexmodule vued">     <picture class="figure__picture">                         <source media="(-webkit-min-device-pixel-ratio: 1.5)" srcset="     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_600/JJ_IM_Logo_SingleLine_Red_RGB.jpg 560w,     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1200/JJ_IM_Logo_SingleLine_Red_RGB.jpg 746w,     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1200/JJ_IM_Logo_SingleLine_Red_RGB.jpg 876w,     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1200/JJ_IM_Logo_SingleLine_Red_RGB.jpg 1022w,     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1800/JJ_IM_Logo_SingleLine_Red_RGB.jpg 1308w,     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1800/JJ_IM_Logo_SingleLine_Red_RGB.jpg 1508w,     https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1800/JJ_IM_Logo_SingleLine_Red_RGB.jpg 1802w " sizes="     (max-width: 759px) calc(100vw - 40px),     (min-width: 760px) and (max-width: 1023px) calc(100vw - 80px),     (min-width: 1024px) and (max-width: 1279px) calc((100vw - 580px) / 12 * 8 + 140px),     (min-width: 1280px) and (max-width: 1424px) calc(100vw - 720px),     (min-width: 1425px) and (max-width: 1579px) calc((100vw - 900px) / 12 * 8 + 140px),     (min-width: 1580px) 607px, 607px "/> <img class="figure__image" src="https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1200/JJ_IM_Logo_SingleLine_Red_RGB.jpg" alt="" width="1000" height="600" loading="lazy" fetchpriority="low"/>                  <photo-lightbox src="https://img.diepresse.com/public/incoming/x2cxlf-JJ_IM_Logo_SingleLine_Red_RGB.jpg/alternates/WEBP_FREE_1800/JJ_IM_Logo_SingleLine_Red_RGB.jpg" caption=""/>     </picture>     <figcaption class="figure__caption">              </figcaption> </figure>  <blockquote class="fm-quote flexmodule flexmodule--quote">     </blockquote> <div class="fm-box flexmodule flexmodule--factbox">     <div class="fm-box__content fm-box__content--serif">         <h2 class="fm-box__title">Fakten</h2><p>J&amp;J Innovative Medicine Austria employs more than 150 people dedicated to making innovations in hematology &amp; oncology, immunology, and neuroscience accessible to patients in Austria.</p><p>More information about J&amp;J’s research activities can be found </p>     </div> </div> <figure class="fm-inlinepicture fm-inlinepicture--small figure flexmodule vued">     <picture class="figure__picture">                         <source media="(-webkit-min-device-pixel-ratio: 1.5)" srcset="     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_600/JJ_Die%20Presse_qrcode.jpeg 560w,     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1200/JJ_Die%20Presse_qrcode.jpeg 746w,     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1200/JJ_Die%20Presse_qrcode.jpeg 876w,     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1200/JJ_Die%20Presse_qrcode.jpeg 1022w,     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1800/JJ_Die%20Presse_qrcode.jpeg 1308w,     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1800/JJ_Die%20Presse_qrcode.jpeg 1508w,     https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1800/JJ_Die%20Presse_qrcode.jpeg 1802w " sizes="     (max-width: 759px) calc(100vw - 40px),     (min-width: 760px) and (max-width: 1023px) calc(100vw - 80px),     (min-width: 1024px) and (max-width: 1279px) calc((100vw - 580px) / 12 * 8 + 140px),     (min-width: 1280px) and (max-width: 1424px) calc(100vw - 720px),     (min-width: 1425px) and (max-width: 1579px) calc((100vw - 900px) / 12 * 8 + 140px),     (min-width: 1580px) 607px, 607px "/> <img class="figure__image" src="https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1200/JJ_Die%20Presse_qrcode.jpeg" alt="" width="1000" height="600" loading="lazy" fetchpriority="low"/>                  <photo-lightbox src="https://img.diepresse.com/public/incoming/mi81z5-JJ_Die-Presse_qrcode.jpeg/alternates/WEBP_FREE_1800/JJ_Die%20Presse_qrcode.jpeg" caption=""/>     </picture>     <figcaption class="figure__caption">              </figcaption> </figure>




    </div>
Michael Brown - Business Editor

Leave a Comment Cancel Reply

About Us

Recent Articles

Ads

J&J: Austria as Key Research Hub – Benefits for People & Economy

Gemínidas 2025: Guide to the Best Meteor Shower Viewing 🌠

Hidden Tenant: 220kg Man Lived Under House for 6 Months | KBS News

You may also like

Leave a Comment Cancel Reply

About Us

Recent Articles

Ads
